TrianglePUBLICATIONS · 32343642
Irinotecan, Temozolomide, and Dinutuximab With GM-CSF in Children With Refractory or Relapsed Neuroblastoma: A Report From the Children's Oncology Group.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- J Clin Oncol
- Publication date
- 2020 Jul 1
- First author
- Mody R
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Mody R
- type
- Author
- name
- Yu AL
- type
- Author
- name
- Naranjo A
- type
- Author
- name
- Zhang FF
- type
- Author
- name
- London WB
- type
- Author
- name
- Shulkin BL
- type
- Author
- name
- Parisi MT
- type
- Author
- name
- Servaes SE
- type
- Author
- name
- Diccianni MB
- type
- Author
- name
- Hank JA
- type
- Author
- name
- Felder M
- type
- Author
- name
- Birstler J
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Mody R
- type
- Author
- name
- Yu AL
- type
- Author
- name
- Naranjo A
- type
- Author
- name
- Zhang FF
- type
- Author
- name
- London WB
- type
- Author
- name
- Shulkin BL
- type
- Author
- name
- Parisi MT
- type
- Author
- name
- Servaes SE
- type
- Author
- name
- Diccianni MB
- type
- Author
- name
- Hank JA
- type
- Author
- name
- Felder M
- type
- Author
- name
- Birstler J
- type
- Author
- bibliography ids
- nci-bib-1aef8ce273a721f50527ab27
- book metadata
- content sha256
- b768d0ce2239170ba8de15e1115bf4d90a563457c917da62fc37bd56d9119613
- document type
- citation
- dois
- 10.1200/JCO.20.00203
- electronic publication date
- display
- 2020 Apr 28
- precision
- day
- year
- 2020
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:32343642
- immutable id
- pubmed:32343642@b768d0ce2239170ba8de15e1115bf4d90a563457c917da62fc37bd56d9119613
- journal
- abbreviation
- J Clin Oncol
- issn electronic
- 1527-7755
- issn print
- 0732-183X
- issue
- 19
- name
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- nlm unique id
- 8309333
- pages
- 2160-2169
- volume
- 38
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 32343642
- provenance
- batch id
- 40d9eae1f1d369f13109
- provider
- NCBI PubMed ESummary
- record sha256
- 8884079ef11f15568c40b1ef322714600725bf7bf0790eb68582f708346fcfff
- response sha256
- 03fa1567b6babd78281d8ec4529596b9d4953c2c4ac23257dca371d609645ba9
- retrieved at
- 2026-09-09T23:47:52.637547+00:00
- publication date
- display
- 2020 Jul 1
- precision
- day
- year
- 2020
- publication types
- Clinical Trial, Phase II
- Journal Article
- Research Support, N.I.H., Extramural
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Irinotecan, Temozolomide, and Dinutuximab With GM-CSF in Children With Refractory or Relapsed Neuroblastoma: A Report From the Children's Oncology Group.
Preserved source evidence · Not medical advice